Ana Lobato Pascual
CEO/CTO & Co-founder
Ana is a Research Coordinator at the Reproductive Medicine group at Oslo University Hospital. Ana holds a PhD in Immunobiology and has extensive experience in laboratory techniques within immunology and molecular biology. She has participated in the coordination of several clinical trials both external and internal. She has training in BioMedical innovation and BioBusiness entrepreneurship. Ana has been working on the development of the technology behind OptimOva® since 2014.
COO & Co-founder
Krister has a broad background from various disciplines and is currently working as a software developer at Dun and Bradstreet. Krister has a background in Biochemistry and is about to deliver his PhD in neuroscience from Oslo university. From 2017 – 2020 he led the data integration and curation efforts in the EU Horizon 2020 FET Flagship project, Human Brain Project – one of the largest innovation projects in Europe. Krister is experienced in leading multidisciplinary teams from countries all over Europe and has extensive knowledge in managing projects within IT and life science.
Mei Ling Lim
CFO & Co-founder
Mei Ling Lim holds a BBnSci (Pharmacology, Neuroscience), GradDipRepSci (Reproductive Sciences), and PhD in Stem Cell research from Monash University, Australia, Executive MBA at Stockholm School of Economics. Mei Ling has ten years of experience managing projects in several therapeutic fields, including immunology, cell therapy, oncology, respiratory medicine, and dermatology with a proven track record of building long term collaborations internationally. Mei Ling is experienced in sales, marketing and exploring business development opportunities in both developed and emerging markets such as Asia Pacific.